Expected earnings - Vincerx Pharma Inc.
Source: US Earnings Reports
Vincerx Pharma Inc. (VINC) is expected to report for Q2 2025
Vincera Pharma Inc Com
NASDAQ: VINC
VINC Trading
-26.3% G/L:
$0.10 Last:
4,482,550 Volume:
$0.1263 Open:
VINC Latest News
VINC Stock Data
$65,428
4,940,477
N/A
3
133314%
Biotechnology & Life Sciences
Healthcare
US
Palo Alto
